ADAR1 Capital Management, LLCinsider trades
In SEC Form 4 filings, ADAR1 Capital Management, LLC is listed as 10% owner of Tenax Therapeutics, Inc. (TENX) and 10% owner of InMed Pharmaceuticals Inc. (INM). In the last 90 days, ADAR1 Capital Management, LLC bought $6.47M across 2 companies on the open market and sold none. The largest purchase was $1.60M of Tenax Therapeutics, Inc. (TENX) on Sep 3. Took part in a cluster buy; the latest at Tenax Therapeutics, Inc. (TENX), where 4 insiders bought within 14 days, ending Sep 16.
Companies and roles
Cluster buys
- TENX: 4 insiders bought $1.74M between Sep 3 – Sep 16.
Form 4 historysince 2026-08-24
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TENXTenax Therapeutics, Inc. | Oct 21 | Oct 21 | P | 331,979 | $1.66 | Purchase +$550,687 | 7,447,000 | No | Form 4 |
| TENXTenax Therapeutics, Inc. | Oct 20 | Oct 21 | P | 254,342 | $1.60 | Purchase +$405,726 | 7,115,021 | No | Form 4 |
| TENXTenax Therapeutics, Inc. | Oct 19 | Oct 21 | P | 336,528 | $1.51 | Purchase +$507,013 | 6,860,679 | No | Form 4 |
| INMInMed Pharmaceuticals Inc. | Oct 19 | Oct 20 | P | 1,086 | $1.32 | Purchase +$1,434 | 956,580 | No | Form 4 |
| INMInMed Pharmaceuticals Inc. | Oct 16 | Oct 20 | P | 1 | $1.32 | Purchase +$1 | 955,494 | No | Form 4 |
| INMInMed Pharmaceuticals Inc. | Oct 15 | Oct 15 | P | 984 | $1.32 | Purchase +$1,301 | 955,493 | No | Form 4 |
| INMInMed Pharmaceuticals Inc. | Oct 14 | Oct 15 | P | 8,021 | $1.33 | Purchase +$10,668 | 954,509 | No | Form 4 |
| INMInMed Pharmaceuticals Inc. | Oct 13 | Oct 15 | P | 564 | $1.33 | Purchase +$750 | 946,488 | No | Form 4 |
| INMInMed Pharmaceuticals Inc. | Oct 8 | Oct 8 | P | 2,256 | $1.33 | Purchase +$2,997 | 945,924 | No | Form 4 |
| INMInMed Pharmaceuticals Inc. | Oct 7 | Oct 8 | P | 3,046 | $1.33 | Purchase +$4,051 | 943,668 | No | Form 4 |
| INMInMed Pharmaceuticals Inc. | Oct 6 | Oct 8 | P | 5,601 | $1.33 | Purchase +$7,436 | 940,622 | No | Form 4 |
| INMInMed Pharmaceuticals Inc. | Oct 5 | Oct 5 | P | 18,182 | $1.33 | Purchase +$24,182 | 935,021 | No | Form 4 |
| INMInMed Pharmaceuticals Inc. | Oct 2 | Oct 5 | P | 8,307 | $1.33 | Purchase +$11,048 | 916,839 | No | Form 4 |
| INMInMed Pharmaceuticals Inc. | Oct 1 | Oct 5 | P | 16,431 | $1.33 | Purchase +$21,850 | 908,532 | No | Form 4 |
| INMInMed Pharmaceuticals Inc. | Sep 16 | Sep 16 | P | 8,340 | $1.29 | Purchase +$10,750 | 892,101 | No | Form 4 |
| INMInMed Pharmaceuticals Inc. | Sep 15 | Sep 16 | P | 54,256 | $1.30 | Purchase +$70,446 | 883,761 | No | Form 4 |
| INMInMed Pharmaceuticals Inc. | Sep 14 | Sep 16 | P | 28,505 | $1.29 | Purchase +$36,880 | 829,505 | No | Form 4 |
| TENXTenax Therapeutics, Inc. | Sep 3 | Sep 8 | P | 900,000 | $1.78 | Purchase +$1,604,160 | 6,524,151 | No | Form 4 |
| TENXTenax Therapeutics, Inc. | Sep 2 | Sep 2 | P | 187,704 | $1.80 | Purchase +$337,586 | 5,624,151 | No | Form 4 |
| TENXTenax Therapeutics, Inc. | Sep 1 | Sep 2 | P | 179,058 | $1.80 | Purchase +$321,570 | 5,436,447 | No | Form 4 |
| TENXTenax Therapeutics, Inc. | Aug 31 | Sep 2 | P | 403,571 | $1.79 | Purchase +$722,594 | 5,257,389 | No | Form 4 |
| TENXTenax Therapeutics, Inc. | Aug 24 | Aug 24 | P | 107,374 | $1.75 | Purchase +$188,355 | 4,853,818 | No | Form 4 |
| TENXTenax Therapeutics, Inc. | Aug 21 | Aug 24 | P | 716,369 | $1.77 | Purchase +$1,266,254 | 4,746,444 | No | Form 4 |
| TENXTenax Therapeutics, Inc. | Aug 20 | Aug 24 | P | 202,124 | $1.78 | Purchase +$359,538 | 4,030,075 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.